Scotia Capital Inc. Purchases 739 Shares of Intuitive Surgical, Inc. $ISRG

Scotia Capital Inc. grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 14.1% in the 2nd quarter, HoldingsChannel reports. The firm owned 5,990 shares of the medical equipment provider’s stock after acquiring an additional 739 shares during the quarter. Scotia Capital Inc.’s holdings in Intuitive Surgical were worth $3,254,000 at the end of the most recent reporting period.

Several other institutional investors have also recently modified their holdings of the company. Tobam lifted its position in Intuitive Surgical by 666.7% in the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 40 shares during the last quarter. TD Capital Management LLC raised its stake in shares of Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 45 shares in the last quarter. 1248 Management LLC bought a new stake in shares of Intuitive Surgical in the 1st quarter worth approximately $30,000. Princeton Global Asset Management LLC bought a new stake in shares of Intuitive Surgical in the 2nd quarter worth approximately $30,000. Finally, CBIZ Investment Advisory Services LLC grew its holdings in shares of Intuitive Surgical by 49.1% during the 1st quarter. CBIZ Investment Advisory Services LLC now owns 82 shares of the medical equipment provider’s stock valued at $41,000 after purchasing an additional 27 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $573.32 on Monday. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The firm has a market cap of $205.52 billion, a P/E ratio of 75.84, a P/E/G ratio of 4.94 and a beta of 1.62. The business’s 50 day moving average price is $505.94 and its 200-day moving average price is $504.62.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. The company had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm’s revenue was up 22.9% on a year-over-year basis. During the same quarter last year, the firm posted $1.84 earnings per share. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 105 shares of Intuitive Surgical stock in a transaction that occurred on Monday, November 10th. The stock was sold at an average price of $560.00, for a total transaction of $58,800.00. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Brian Edward Miller sold 3,500 shares of the stock in a transaction that occurred on Monday, November 10th. The stock was sold at an average price of $575.00, for a total value of $2,012,500.00. Following the completion of the transaction, the executive vice president directly owned 5,758 shares of the company’s stock, valued at $3,310,850. This represents a 37.81% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 86,804 shares of company stock worth $48,043,866. 0.70% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on ISRG. Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Robert W. Baird set a $655.00 target price on Intuitive Surgical in a report on Wednesday, October 22nd. Piper Sandler raised their price target on Intuitive Surgical from $595.00 to $610.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 22nd. Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a research report on Friday, October 31st. Finally, Jefferies Financial Group raised their target price on shares of Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a report on Wednesday, October 22nd. Two analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $608.92.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.